OTC Products - Sierra Leone

  • Sierra Leone
  • Sierra Leone is expected to witness a significant growth in its OTC Products market.
  • The projected revenue for this market in Sierra Leone is estimated to reach US$168.60m by 2024.
  • Furthermore, it is anticipated that this market will experience a steady annual growth rate (CAGR 2024-2029) of 3.27%, resulting in a market volume of US$198.00m by 2029.
  • In comparison to other countries, China is projected to generate the highest revenue in the global OTC Products market, with an estimated revenue of US$74.91bn in 2024.
  • When considering the population figures, it is noteworthy that per person revenues in Sierra Leone are expected to reach US$18.77 in 2024.
  • This indicates the potential for growth and profitability in the OTC Products market in Sierra Leone.
  • Sierra Leone's OTC market is experiencing a surge in demand for traditional herbal remedies due to their cultural significance and perceived health benefits.

Key regions: Europe, Australia, United Kingdom, Germany, South Korea

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Products (Pharmacies) market in Sierra Leone is experiencing significant growth and development.

Customer preferences:
Customers in Sierra Leone have shown a growing preference for OTC products in recent years. This can be attributed to several factors, including increased awareness about self-care and the convenience of purchasing medications without a prescription. Additionally, the affordability of OTC products compared to prescription drugs has also contributed to their popularity among consumers.

Trends in the market:
One of the key trends in the OTC Products (Pharmacies) market in Sierra Leone is the increasing demand for vitamins and dietary supplements. This can be attributed to a growing focus on health and wellness among consumers, as well as an increased understanding of the importance of preventive healthcare. Consumers are increasingly seeking OTC products that can help them maintain their overall health and well-being. Another trend in the market is the rising demand for OTC pain relief medications. This can be attributed to the high prevalence of conditions such as headaches, muscle aches, and joint pain among the population. Consumers are looking for effective and affordable OTC products to alleviate their pain and discomfort.

Local special circumstances:
Sierra Leone is a developing country with a significant portion of the population living in rural areas. Access to healthcare facilities, including pharmacies, can be limited in these areas. As a result, OTC products play a crucial role in providing essential healthcare services to the population. Pharmacies in Sierra Leone often serve as the first point of contact for individuals seeking healthcare advice and treatment options.

Underlying macroeconomic factors:
Sierra Leone has experienced steady economic growth in recent years, which has contributed to an increase in disposable income among consumers. This has enabled more people to afford OTC products and has fueled the growth of the market. Additionally, the government's efforts to improve healthcare infrastructure and promote access to healthcare services have also played a role in the development of the OTC Products (Pharmacies) market in Sierra Leone. In conclusion, the OTC Products (Pharmacies) market in Sierra Leone is witnessing significant growth and development. Customer preferences for OTC products, such as vitamins, dietary supplements, and pain relief medications, are driving the market's expansion. The local special circumstance of limited access to healthcare facilities in rural areas further emphasizes the importance of OTC products in providing essential healthcare services. The underlying macroeconomic factors, including economic growth and government initiatives, have also contributed to the market's development.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Sales Channels
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)